Balchem Stock Market Outlook
| BCPC Stock | USD 180.81 3.32 1.87% |
About 69 percent of all Balchem's shareholders are curious in acquiring. The analysis of overall sentiment of trading Balchem stock suggests that quite a large number of investors are confidant at this time. The current market sentiment, together with Balchem's historical and current headlines, can help investors time the market. In addition, many technical investors use Balchem stock news signals to limit their universe of possible portfolio assets.
Comfort Level 69
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Balchem's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Balchem.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Balchem is 'Strong Buy'. Macroaxis provides Balchem buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Balchem positions.
Execute Balchem Advice
The Balchem recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Balchem. Macroaxis does not own or have any residual interests in Balchem or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Balchem's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
![]() | ![]() |
Strong Buy
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Tiny | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
For the selected time horizon Balchem has a Risk Adjusted Performance of 0.1481, Jensen Alpha of 0.1929, Total Risk Alpha of 0.1361, Sortino Ratio of 0.1901 and Treynor Ratio of 0.3034Macroaxis provides advice on Balchem to complement and cross-verify current analyst consensus on Balchem. Our investment recommendation engine determines the company's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Balchem is not overpriced, please confirm all Balchem fundamentals, including its shares owned by institutions, gross profit, debt to equity, as well as the relationship between the price to book and cash and equivalents . Given that Balchem has a price to earning of 42.37 X, we suggest you to validate Balchem market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.
Balchem Trading Alerts and Improvement Suggestions
| Balchem has a strong financial position based on the latest SEC filings | |
| Over 92.0% of the company shares are held by institutions such as insurance companies | |
| On 20th of January 2026 Balchem paid $ 0.96 per share dividend to its current shareholders | |
| Latest headline from news.google.com: Acquisition by Vicente Monica of 870 shares of Balchem subject to Rule 16b-3 |
Balchem Returns Distribution Density
The distribution of Balchem's historical returns is an attempt to chart the uncertainty of Balchem's future price movements. The chart of the probability distribution of Balchem daily returns describes the distribution of returns around its average expected value. We use Balchem price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Balchem returns is essential to provide solid investment analysis for Balchem.
| Mean Return | 0.25 | Value At Risk | -1.53 | Potential Upside | 3.26 | Standard Deviation | 1.40 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Balchem historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Balchem Stock Institutional Investors
| Shares | Jpmorgan Chase & Co | 2025-06-30 | 451.7 K | Schroder Investment Management Group | 2025-06-30 | 407.5 K | Northern Trust Corp | 2025-06-30 | 395.5 K | Charles Schwab Investment Management Inc | 2025-06-30 | 368.5 K | Congress Asset Management Company, Llp | 2025-06-30 | 362.1 K | Grantham, Mayo, Van Otterloo & Co., Llc | 2025-06-30 | 352.5 K | Nuveen, Llc | 2025-06-30 | 345.5 K | Clearbridge Advisors, Llc | 2025-06-30 | 335.8 K | Stephens Inv Mgmt Group Llc | 2025-06-30 | 275.4 K | Blackrock Inc | 2025-06-30 | 4.9 M | Vanguard Group Inc | 2025-06-30 | 3.9 M |
Balchem Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change To Inventory | (21.0M) | (7.8M) | 10.5M | (22.8M) | (20.5M) | (19.5M) | |
| Free Cash Flow | 123.1M | 88.2M | 145.9M | 146.3M | 168.3M | 176.7M | |
| Depreciation | 48.9M | 51.8M | 54.9M | 48.0M | 55.2M | 57.9M | |
| Capital Expenditures | 37.4M | 50.3M | 37.9M | 35.7M | 41.0M | 43.1M | |
| Net Income | 96.1M | 105.4M | 108.5M | 128.5M | 147.7M | 155.1M | |
| Change In Cash | 18.7M | (36.7M) | (2.1M) | (14.9M) | (13.4M) | (12.8M) | |
| Other Non Cash Items | (257K) | 1.7M | (5.0M) | 1.8M | 1.6M | 1.7M | |
| Dividends Paid | 18.7M | 20.7M | (22.9M) | (25.6M) | (23.0M) | (21.9M) | |
| End Period Cash Flow | 103.2M | 66.6M | 64.4M | 49.5M | 56.9M | 46.5M | |
| Change To Netincome | 2.8M | 6.1M | 4.6M | 5.2M | 6.0M | 6.3M | |
| Change Receivables | 11.6M | (3.6M) | (20.7M) | (3.6M) | (3.3M) | (3.4M) | |
| Net Borrowings | (55.2M) | 299.8M | (131.2M) | (119.8M) | (107.8M) | (102.4M) | |
| Investments | (35.3M) | (150K) | (37.4M) | (59.7M) | (68.7M) | (72.1M) |
Balchem Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Balchem or Chemicals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Balchem's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Balchem stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.19 | |
β | Beta against Dow Jones | 0.79 | |
σ | Overall volatility | 1.44 | |
Ir | Information ratio | 0.13 |
Balchem Volatility Alert
Balchem has low volatility with Treynor Ratio of 0.3, Maximum Drawdown of 7.13 and kurtosis of 0.81. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Balchem's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Balchem's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Balchem Fundamentals Vs Peers
Comparing Balchem's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Balchem's direct or indirect competition across all of the common fundamentals between Balchem and the related equities. This way, we can detect undervalued stocks with similar characteristics as Balchem or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Balchem's fundamental indicators could also be used in its relative valuation, which is a method of valuing Balchem by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Balchem to competition |
| Fundamentals | Balchem | Peer Average |
| Return On Equity | 0.12 | -0.31 |
| Return On Asset | 0.0787 | -0.14 |
| Profit Margin | 0.15 % | (1.27) % |
| Operating Margin | 0.20 % | (5.51) % |
| Current Valuation | 5.87 B | 16.62 B |
| Shares Outstanding | 32.39 M | 571.82 M |
| Shares Owned By Insiders | 0.30 % | 10.09 % |
| Shares Owned By Institutions | 91.86 % | 39.21 % |
| Number Of Shares Shorted | 294.2 K | 4.71 M |
| Price To Earning | 42.37 X | 28.72 X |
| Price To Book | 4.44 X | 9.51 X |
| Price To Sales | 5.79 X | 11.42 X |
| Revenue | 953.68 M | 9.43 B |
| Gross Profit | 363.07 M | 27.38 B |
| EBITDA | 230.95 M | 3.9 B |
| Net Income | 128.47 M | 570.98 M |
| Cash And Equivalents | 58.1 M | 2.7 B |
| Cash Per Share | 1.81 X | 5.01 X |
| Total Debt | 208.04 M | 5.32 B |
| Debt To Equity | 0.53 % | 48.70 % |
| Current Ratio | 2.59 X | 2.16 X |
| Book Value Per Share | 40.09 X | 1.93 K |
| Cash Flow From Operations | 182 M | 971.22 M |
| Short Ratio | 1.92 X | 4.00 X |
| Earnings Per Share | 4.57 X | 3.12 X |
| Price To Earnings To Growth | 4.76 X | 4.89 X |
| Target Price | 191.0 | |
| Number Of Employees | 1.35 K | 18.84 K |
| Beta | 0.95 | -0.15 |
| Market Capitalization | 5.87 B | 19.03 B |
| Total Asset | 1.58 B | 29.47 B |
| Retained Earnings | 997.49 M | 9.33 B |
| Working Capital | 156.09 M | 1.48 B |
Note: Disposition of 2416 shares by Carl Bengtsson of Balchem at 178.68 subject to Rule 16b-3 [view details]
Balchem Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Balchem . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Balchem Buy or Sell Advice
When is the right time to buy or sell Balchem? Buying financial instruments such as Balchem Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Balchem in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Robots And Drones Thematic Idea Now
Robots And Drones
Large technology companies that are involved in development and manufacturing of drones, robots, or robotic equipment across mechanical engineering, electrical engineering, mathematics and computer science fields. Drones and robotics are projected to significantly grow in demand in the next 5 years. The Robots And Drones theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Robots And Drones Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Balchem Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Will Specialty Chemicals sector continue expanding? Could Balchem diversify its offerings? Factors like these will boost the valuation of Balchem. Projected growth potential of Balchem fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Balchem data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.204 | Dividend Share 0.87 | Earnings Share 4.57 | Revenue Per Share | Quarterly Revenue Growth 0.115 |
The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Balchem's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Balchem should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Balchem's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.


